NCT05176080 2024-12-17
Famitinib Plus SHR6390 and Endocrine Therapy in the Treatment of HR-positive, HER2-negative Advanced Breast Cancer
Henan Cancer Hospital
Phase 1/2 Terminated
Clinical Trials
6 trialsNCT00193726 2018-09-20
Estrogen Priming to Increase the Efficacy of Adjuvant Chemotherapy in Operable Breast Cancer
Tata Memorial Hospital
Phase 3 Terminated
NCT01939418 2017-10-03
Phase Ib/II Trials of RAD001 in Triple Negative Metastatic Breast Cancer
National Cancer Center, Korea
Phase 1/2 Terminated
NCT00128362 2014-06-24
Sentinel Node Biopsy and Axillary Sampling in Operable Breast Cancer
Tata Memorial Hospital
Phase 2 Terminated
NCT00532285 2011-06-23
Primary Paclitaxel Plus Gemcitabine in Patients With Stage II and III Breast Cancer
National Cancer Center, Korea
Phase 2 Terminated
NCT00532454 2010-02-10
Evaluation of the Association Between CYP2D6 Genetic Polymorphisms and the Treatment Effect of Tamoxifen
National Cancer Center, Korea
Phase 2 Terminated